6.6.1 Diagnosis and treatment using radiation
Treating tumours with radiation
Radiotherapy
Radiotherapy is the treatment of a tumour with high-energy ionising radiation in order to kill cancer cells or stop them dividing.
- The radiation used is high-energy gamma rays or high-energy X-rays, because only very penetrating radiation can reach a tumour buried inside the body.
- As the radiation passes through a cell it ionises molecules, and the damage that matters most is the damage done to the cell's DNA.
- A cell with badly damaged DNA cannot copy it correctly, so the cell fails when it next tries to divide and it dies.
- Tumour cells divide far more often than most healthy cells and are worse at repairing DNA damage, so the same dose kills a much greater share of them.
- Healthy cells in the path of the radiation are damaged too, which is what causes the side effects of treatment, so every method of delivering the radiation is designed to give the largest possible dose to the tumour and the smallest possible dose everywhere else.
- The total dose is usually split into many small fractions given on different days, which gives healthy tissue time to repair between sessions while the tumour is worn down.
- The radiation can be delivered from a machine outside the body or from a source placed inside it.
External radiotherapy
- A machine outside the patient produces a narrow beam of high-energy radiation and directs it at the tumour, so no radioactive material ever enters the body.
- The beam is shaped by a collimator so that its cross-section matches the outline of the tumour as closely as possible.
- The machine is then rotated around the patient, so the beam enters the body from many different directions during the session.
- Every beam direction passes through the tumour, so the tumour receives the sum of all the doses and ends up with a very large total.
- Any one region of healthy tissue lies in the path of only one or two of those directions, so it receives a much smaller total than the tumour does.
- Advantages: nothing is implanted, so no surgery is needed; the patient is not radioactive at any point and can go home straight away; deep tumours can be reached; and the direction, shape and size of the dose can be adjusted between sessions.
- Disadvantages: the radiation has to travel through healthy tissue on its way in and out, side effects such as tiredness, reddened skin and hair loss in the treated area are common, many sessions are needed over several weeks, and the patient must be positioned very accurately each time.
Internal radiotherapy
- A radioactive source is placed inside the body, either in the tumour itself or immediately next to it.
- The source may be a small sealed pellet or rod inserted during a short procedure, or a radioactive substance that the body itself concentrates in the target tissue.
- An overactive thyroid or a thyroid tumour, for example, can be treated with radioactive iodine, because the thyroid gland absorbs iodine from the blood whether or not the nuclei are stable.
- The radiation spreads out from the source in all directions, so its intensity falls rapidly with distance.
- Tissue touching the source therefore receives an extremely large dose while tissue a few centimetres further away receives very little, which is exactly the pattern the treatment wants.
- Advantages: the tumour gets a very high dose, healthy tissue further away is largely spared, treatment continues steadily while the source stays in place, and fewer hospital visits are needed.
- Disadvantages: placing the source usually needs an invasive procedure, staff have to handle a radioactive source, the patient is radioactive while the source is inside them and so must limit close contact with visitors, and the method only suits tumours that can be reached or that take up a particular substance.
- Both treatments use ionising radiation to damage the DNA of cancer cells so they cannot divide.
- The difference is where the source is: outside the body and aimed in, or inside the body and already at the target.
- External treatment spares healthy tissue by crossing beams, internal treatment spares it by being close.
Tracers in diagnosis
Radioactive tracer
A radioactive tracer is a small quantity of a radioactive substance added to a system so that its position or movement can be followed using a radiation detector.
- A tracer is swallowed, injected or inhaled, depending on which organ is being investigated, and is carried around the body by the blood.
- The radioactive atoms are attached to a chemical the target tissue takes up naturally, so the tracer collects where the doctor wants to look.
- A gamma camera outside the patient detects the radiation coming out and builds a picture of where the tracer has gone.
- A medical tracer must be a gamma emitter, because gamma radiation is the only kind penetrating enough to escape the body and reach the camera; alpha and beta radiation would be absorbed by the surrounding tissue and would only add to the patient's dose.
- It must also have a short half-life, long enough for the scan to be completed but short enough that the activity inside the patient falls away within hours rather than years.
- Technetium-99m is the isotope used most often, because it emits gamma radiation only and has a half-life of about 6 hours6\ \text{hours}6 hours.
- The doctor is looking for tissue that takes up more or less tracer than expected, since that pattern shows how the organ is working rather than just what shape it is.
- Tracers are used to follow blood flow, to check how well a kidney or a thyroid gland is functioning, to find blockages in the circulation or the digestive system, and to locate secondary tumours in bone.
How a PET scanner works
PET scan
A PET scan is a medical image built from the gamma rays produced when positrons emitted by a tracer inside the body meet electrons in nearby tissue.
Positron
A positron is the antiparticle of the electron, with the same mass as an electron but a positive charge.
- The patient is injected with a tracer whose nuclei emit positrons rather than gamma rays, most often fluorine-18 attached to a molecule that behaves like glucose.
- Tissue that is working hardest uses the most glucose, so the most active tissue, including many tumours, takes up the most tracer.
- Each emitted positron travels only a very short distance through tissue before it meets an electron, of which there are enormous numbers in every atom around it.
- A positron and an electron are a particle and its antiparticle, so when they meet they annihilate: both are destroyed and their mass is converted into energy.
- That energy leaves as two gamma rays travelling in opposite directions, which is required because the pair had almost no momentum before they met.
- A ring of detectors surrounds the patient, and the electronics look for two gamma rays arriving on opposite sides of the ring at almost the same instant.
- Each such pair of detections means an annihilation happened somewhere along the straight line joining the two detectors.
- A computer collects millions of these lines and finds the regions where they cross most often, and those regions are where the tracer is concentrated.
- The result is a three-dimensional image showing how active each part of the body is, which is information that an X-ray image of structure alone cannot give.
- PET scans are used to find tumours, to check whether a tumour is still active after treatment, and to study how the brain and the heart are working.
Making PET isotopes nearby
- The isotopes that emit positrons have very short half-lives: about 110 minutes110\ \text{minutes}110 minutes for fluorine-18 and only about 20 minutes20\ \text{minutes}20 minutes for carbon-11.
- A short half-life is chosen deliberately, because it means the activity inside the patient falls away within a few hours and the dose is kept small.
- The same property applies before the scan as well, so the activity is falling steeply from the moment the isotope is made.
- A long journey would use up several half-lives, and once too few nuclei are left the number of annihilations per second is too small to build a clear image.
- Giving the patient a much larger amount to compensate is not an option, because that would raise the dose and undo the reason for using a short-lived isotope.
- The isotopes are therefore made in a cyclotron on the hospital site or at a centre close to it, attached to the tracer molecule immediately, and injected within a few hours.
- This is why PET scanning is expensive and why it is available at far fewer hospitals than ordinary X-ray imaging.
Activity lost in transport
- A batch of fluorine-18, half-life 110 minutes110\ \text{minutes}110 minutes, is made at a cyclotron with an activity of 800 MBq800\ \text{MBq}800 MBq.
- Preparing it and driving it to a distant hospital takes 220 minutes220\ \text{minutes}220 minutes.
- The number of half-lives is n=tT1/2=220110=2n=\dfrac{t}{T_{1/2}}=\dfrac{220}{110}=2n=T1/2t=110220=2.
- Using A=A0(12)nA=A_{0}\left(\dfrac{1}{2}\right)^{n}A=A0(21)n gives A=800×(12)2=200 MBqA=800\times\left(\dfrac{1}{2}\right)^{2}=200\ \text{MBq}A=800×(21)2=200 MBq.
- Three quarters of the activity has been lost before the tracer even reaches the patient.
- Carbon-11, with a half-life of 20 minutes20\ \text{minutes}20 minutes, would pass through eleven half-lives in the same journey and arrive with less than one thousandth of its activity, which is why it can only be used where it is made.
Comparing and explaining
- For a compare question on treatment, give at least one similarity and one difference, and make the difference about where the source is rather than about which is better.
- When you justify a property of a tracer, link it to a consequence: gamma so the radiation can leave the body, short half-life so the activity soon falls and the dose stays low.
- For PET, describe the whole chain in order, because each stage is a separate marking point: tracer injected, positron emitted, positron meets electron, annihilation, two gamma rays in opposite directions, detected by a ring, computer builds the image.
- For the question about producing isotopes nearby, three linked steps are needed: short half-life, activity falls quickly during transport, too little activity left for a clear scan.
- Where numbers are given, work in half-lives first, since n=tT1/2n=\dfrac{t}{T_{1/2}}n=T1/2t is usually worth a mark of its own.
- Do not say a PET tracer emits gamma rays directly; it emits positrons, and the gamma rays are produced when a positron meets an electron.
- Do not say the two gamma rays travel in the same direction; they travel in opposite directions, which is what allows the position to be worked out.
- Do not choose an alpha or beta emitter as a tracer; the radiation would never get out of the patient to be detected.
- Do not say a short half-life is chosen only to protect the patient; it is also the reason the isotope cannot be transported far.
- Do not write that external radiotherapy leaves the patient radioactive; only internal treatment puts a source inside the body.
- Do not claim radiotherapy affects only cancer cells; healthy cells in the beam are damaged as well, which is why the dose is spread over many sessions.
- Explain why cancer cells are killed by a dose of radiation that healthy cells survive.
- Explain how rotating the beam around the patient protects healthy tissue during external radiotherapy.
- Give one similarity and two differences between internal and external treatment of a tumour.
- State the two properties a medical tracer must have and explain why each is needed.
- Describe, in order, what happens between a positron being emitted and a PET image appearing.
- Explain why isotopes used in PET scanners have to be produced close to the scanner.